Przerzutowy rak jelita grubego: badanie fazy III leku M9140 i bevacizumab
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal…